ALFA FinderBSE filing, NSE: HCG. Summary written from the filing by ALFA Finder's alert engine.
Healthcare Global Enterprises Ltd: key numbers
- Share price
- ₹600.25
- Market cap
- ₹8,962 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 793.1×Sector 53.9×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthcare Global Enterprises Ltd
All →Healthcare Global Enterprises Earnings Call Transcript: Key Takeaways
Q2 revenue ₹732 Cr, +16% YoY; H1 ₹1,410 Cr, +15%. EBITDA margin 19.7% despite ~₹6 Cr wage-revision hit. Trade-margin cap guided at mid-to-high single-digit annualised impact, with few specifics.
Healthcare Global Enterprises Results Update
HCG reported Q2 FY27 revenue of INR 7,318 Mn, up 16% YoY, with adjusted EBITDA up 17%. Results cover the quarter and half-year ended September 30, 2026.
Healthcare Global Enterprises Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 7,318 Mn (+16% YoY) and Adjusted EBITDA INR 1,425 Mn (+17%, 19.7% margin). Reported PAT INR 92.5 Mn. Plan to add 1,000 beds by FY30.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Healthcare Global Enterprises Q2 FY27 Results: Net Profit ₹9.2 Cr, Down 55.6% YoY
Healthcare Global Enterprises Ltd reported revenue from operations of ₹731.8 Cr (+13.1% YoY) and net profit of ₹9.2 Cr (-55.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹9.2 Cr · -55.6% YoY
Healthcare Global Enterprises Other Announcement
HealthCare Global Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Other business update announcements
All →Italian Edibles Business Update
Italian Edibles revised its project timeline again, pushing commercial production from January 2027 to April 2027. Construction delays stem from steel prices, supply chain disruption, weather and labour shortages.
- Execution
- Commercial production revised to April 2027 from January 2027
Bajaj Finserv Business Update
Bajaj Finserv disclosed October 2026 monthly premium and new business data for its unlisted insurance subsidiaries. The figures are provisional.
Bajaj Finance Business Update
Bajaj Finance submitted its Half Yearly Report for FY2026-27 covering the six months to 30 September 2026. The report shows 28% consolidated PAT growth to ₹12,447 crore and a planned ₹17,500 crore capital raise.
Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Pashamylaram facility, classifying the inspection as Voluntary Action Indicated. The inspection is now concluded.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.
Purple Wave Infocom Business Update
Purple Wave signed a 5-year data integration agreement with BPCL for its Hygiair devices. The Rs 10 crore figure is indicative, not firm order value.
- Execution
- 5 years